JNJ-64407564

Overview

JNJ-64407564 is a bispecific monoclonal antibody binds to both CD3 on T cells and GPRC5D expressed on certain tumor cells.

SparkCures ID 306
Developed By Janssen Research & Development
Generic Name JNJ-64407564
Treatment Classifications
Treatment Targets

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.